The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With ESRD

NCT06982573 | Recruiting

• 1 other identifier: 2025-01-031
• Study Type: interventional
• Target: 18
• Locations: 1 country
• Sites: 1

Brief Summary

To determine the effectiveness of magnetic stimulation application on alleviating back pain and maintaining muscle mass in patients with end-stage renal disease.

Conditions

End-Stage Renal Disease

Outcome Measures

Primary Outcomes (1)

• Visual Analogue Sclae (VAS)

  An assessment in which the subject quantifies the level of pain numerically from 0 to 10. The higher the number, the more intense the pain.

  7 days before intervention/1 day after intervention/1 month after intervention

Secondary Outcomes (4)

• Short Physical Performance Battery (SPPB)

  7 days before intervention/1 day after intervention/1 month after intervention

• The World Health Organization (WHOQOL-BREF)

  7 days before intervention/1 day after intervention/1 month after intervention

• 3D Motion Capture

  7 days before intervention/1 day after intervention/1 month after intervention

• Dual Energy X-ray Absorptionmetry (DEXA)

  7 days before intervention/1 day after intervention/1 month after intervention

Study Arms (1)

End-Stage Renal Disease patients

EXPERIMENTAL

Device: Effects of applying magnetic stimulation

Interventions

Effects of applying magnetic stimulation DEVICE

The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients with End-Stage Renal Disease (ESRD)

End-Stage Renal Disease patients

Eligibility Criteria

• Age: 19 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults aged 19 years or older
• Patients diagnosed with end-stage renal failure and receiving dialysis treatment more than three times a week
• Back pain intensity of 4 points or higher on the visual analogue scale (VAS)
• Those with cognitive function that can clearly indicate NRS with a score of 23 points or higher, the criterion for determining cognitive impairment on the Mini Mental State Examination (MMSE) \[14\]
• Those who voluntarily decided to participate in this clinical trial after receiving a detailed explanation and fully understanding it and gave written consent to comply with the precautions

You may not qualify if:

• If the pain is due to trauma
• If it is difficult to participate in the study due to serious mental illness (e.g. schizophrenia, bipolar disorder, etc.) or psychological instability.
• Patients with severe neurological illness (e.g. stroke, severe dementia, etc.).
• Those with poor general condition due to unstable cardiovascular, digestive, respiratory, or endocrine systems, or severe internal medical illness such as systemic infection
• Patients participating in other therapeutic clinical trials or those who have participated in other therapeutic clinical trials within the past 30 days (observational studies are not relevant)
• If there are contraindications to magnetic stimulation
• Patients with implanted medical devices (e.g. pacemakers)
• Metal objects are inserted into the skull
• A wound on the skin at the attachment site
• History of epilepsy
• Cervical pain or musculoskeletal disease
• Pregnant and lactating women

Sponsors & Collaborators

• Bundang CHA Hospital: lead

Study Sites (1)

CHA Bundang Medical Center, CHA University

Seongnam-si, Gyeonggi-do, 463-712, South Korea

RECRUITING

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, Chronic; Renal Insufficiency; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Kim Minyoung, M.D., Ph.D

  Bundang CHA Hospital

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Chung Eun Hye, M.S

CONTACT

+821032657071; a230419@chamc.co.kr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principle investigator

Study Record Dates

• First Submitted: May 11, 2025
• First Posted: May 21, 2025
• Study Start: August 6, 2025
• Primary Completion: February 19, 2026
• Study Completion: February 19, 2026
• Last Updated: September 19, 2025

Record last verified: 2025-09

Data Sharing

• IPD Sharing: Will not share

Locations

KR (1)